Pfizer Stops Developing Weight-Loss Pill [QL7aHypLj1Z]

| 1h 28m 28s | Video has closed captioning.

Pfizer stops developing its experimental weight-loss pill. More than half of patients in the study had to stop taking danuglipron due to nausea and vomiting, according to a statement Friday. The shares dropped 3.4% in trading before US markets opened. Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: Connect with us on... Twitter: Facebook: Instagram:

Aired: December 12, 2024

Rating: TV-14